Table 1.
Baseline characteristics of patients with and without anastomotic leakage
| Variables | Anastomotic leakage (n = 40) | No anastomotic leakage (n = 112) |
|---|---|---|
| Age (median, range) | 64 (39–78) | 66 (42–81) |
| BMI (median, range) | 26 (19–43) | 25 (16–36) |
|
Gender Male |
35 (88%) | 84 (75%) |
| Comorbidities | 32 (80%) | 80 (71%) |
|
ASA-score 1 2 3 4 |
3 (8%) 22 (55%) 15 (38%) |
12 (11%) 68 (61%) 29 (26%) 1 (1%) |
|
Neoadjuvant therapy Chemoradiotherapy None Chemoterhapy |
37 (93%) 3 (8%) |
100 (89%) 8 (7%) 4 (3%) |
|
Clinical T Stage cT1 cT2 cT3 cT4 |
3 (8%) 10 (25%) 25 (63%) 2 (5%) |
7 (6%) 19 (17%) 81 (72%) 5 (5%) |